Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Effect of Interval Aerobic Training and Mindfulness Breathing on Hormonal, Metabolic, and Tumor Markers in Postmenopausal 07/15/2020 INTERVENTIONAL unchanged 2,233.85 0 PREPARE: Patient Centered Perioperative Experience 07/15/2020 INTERVENTIONAL unchanged 2,233.85 0 A Prospective Study of a Mosaic Embryo Transfer 07/15/2020 INTERVENTIONAL unchanged 2,233.85 0 HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART). 07/15/2020 INTERVENTIONAL unchanged 2,233.85 0 Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer 07/16/2020 INTERVENTIONAL unchanged 2,232.85 0 Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) 07/16/2020 INTERVENTIONAL unchanged 2,232.85 0 Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study 07/17/2020 OBSERVATIONAL unchanged 2,231.85 0 Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy 07/20/2020 OBSERVATIONAL unchanged 2,228.85 0 Affect of Duavive on Mood & Anxiety Symptoms 07/20/2020 INTERVENTIONAL unchanged 2,228.85 0 Transvaginal Mesh vs. Laparoscopic Colposacropexy- Study 07/21/2020 INTERVENTIONAL unchanged 2,227.85 0 Aspirin and Preeclampsia 07/21/2020 INTERVENTIONAL unchanged 2,227.85 0 Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions 07/21/2020 INTERVENTIONAL unchanged 2,227.85 0 Clinical and Molecular Study of Endometriosis and Adenomyosis 07/22/2020 OBSERVATIONAL unchanged 2,226.85 0 A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast 07/22/2020 INTERVENTIONAL unchanged 2,226.85 0 Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer 07/22/2020 INTERVENTIONAL unchanged 2,226.85 0 RCT of CBD for Anxiety in Advanced Breast Cancer 07/22/2020 INTERVENTIONAL unchanged 2,226.85 0 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer 07/24/2020 INTERVENTIONAL unchanged 2,224.85 0 Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer 07/24/2020 OBSERVATIONAL unchanged 2,224.85 0 Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial 07/27/2020 INTERVENTIONAL unchanged 2,221.85 0 A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer 07/27/2020 INTERVENTIONAL unchanged 2,221.85 0 Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy 07/31/2020 INTERVENTIONAL unchanged 2,217.85 0 A Study to Identify Breast Cancer (IDBC) 07/31/2020 OBSERVATIONAL unchanged 2,217.85 0 CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer 08/03/2020 OBSERVATIONAL unchanged 2,214.85 0 Poke and a Placebo 08/04/2020 INTERVENTIONAL unchanged 2,213.85 0 Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery 08/04/2020 INTERVENTIONAL unchanged 2,213.85 0 Peripartum Mental Health Cohort Study in Guangzhou 08/05/2020 OBSERVATIONAL unchanged 2,212.85 0 Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria 08/06/2020 INTERVENTIONAL unchanged 2,211.85 0 A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC 08/06/2020 INTERVENTIONAL unchanged 2,211.85 0 European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III 08/07/2020 OBSERVATIONAL unchanged 2,210.85 0 Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy 08/07/2020 OBSERVATIONAL unchanged 2,210.85 0 Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer 08/11/2020 INTERVENTIONAL unchanged 2,206.85 0 Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer 08/12/2020 INTERVENTIONAL unchanged 2,205.85 0 CONFIRM EXTENSION - Long-term Follow-up Study of Patients Treated with AGN1 LOEP 08/13/2020 INTERVENTIONAL unchanged 2,204.85 0 Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal 08/13/2020 INTERVENTIONAL unchanged 2,204.85 0 Mindfulness in Endometrial and Cervical Cancer 08/13/2020 INTERVENTIONAL unchanged 2,204.85 0 Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel 08/17/2020 INTERVENTIONAL unchanged 2,200.85 0 Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers 08/18/2020 INTERVENTIONAL unchanged 2,199.85 0 A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer 08/18/2020 INTERVENTIONAL unchanged 2,199.85 0 Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer 08/18/2020 INTERVENTIONAL unchanged 2,199.85 0 Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer 08/18/2020 INTERVENTIONAL unchanged 2,199.85 0 Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis 08/18/2020 INTERVENTIONAL unchanged 2,199.85 0 Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer 08/18/2020 OBSERVATIONAL unchanged 2,199.85 0 Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer 08/19/2020 INTERVENTIONAL unchanged 2,198.85 0 Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer 08/19/2020 INTERVENTIONAL unchanged 2,198.85 0 Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women 08/20/2020 INTERVENTIONAL unchanged 2,197.85 0 Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) 08/20/2020 INTERVENTIONAL unchanged 2,197.85 0 Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT 08/20/2020 INTERVENTIONAL unchanged 2,197.85 0 Impact of Room Light on Uterine Contractions and Labor Progression in Pregnancy 08/21/2020 INTERVENTIONAL unchanged 2,196.85 0 The Effect of Pain Neuroscience Education and Behavioural Graded Activity on Chronic Pain in Breast Cancer Survivors 08/31/2020 INTERVENTIONAL unchanged 2,186.85 0 PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders) 08/31/2020 INTERVENTIONAL unchanged 2,186.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology